These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21142442)

  • 1. Inhibition of vesicular stomatitis virus replication in the course of HIV infection in patients with different stages of immunodeficiency.
    Piasecki E; Knysz B; Zwolińska K; Gąsiorowski J; Lorenc M; Zalewska M; Gładysz A; Siemieniec I; Pazgan-Simon M
    Viral Immunol; 2010 Dec; 23(6):567-76. PubMed ID: 21142442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudotypes of vesicular stomatitis virus-bearing envelope antigens of certain HIV-1 strains permissively infect human syncytiotrophoblasts cultured in vitro: implications for in vivo infection of syncytiotrophoblasts by cell-free HIV-1.
    Bácsi A; Ebbesen P; Szabó J; Beck Z; Andirkó I; Csoma E; Tóth FD
    J Med Virol; 2001 Aug; 64(4):387-97. PubMed ID: 11468721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
    Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
    Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative multiplex assay for simultaneous detection of the Indiana serotype of vesicular stomatitis virus and HIV gag.
    Coleman JW; Ogin-Wilson E; Johnson JE; Nasar F; Zamb TP; Clarke DK; Hendry RM; Udem SA
    J Virol Methods; 2007 Jul; 143(1):55-64. PubMed ID: 17382412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
    Bartz SR; Vodicka MA
    Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
    Trottier MD; Palian BM; Reiss CS
    Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia.
    Césaire R; Olière S; Sharif-Askari E; Loignon M; Lézin A; Olindo S; Panelatti G; Kazanji M; Aloyz R; Panasci L; Bell JC; Hiscott J
    Oncogene; 2006 Jan; 25(3):349-58. PubMed ID: 16186807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: potential role of human papilloma virus infection.
    Le Boeuf F; Niknejad N; Wang J; Auer R; Weberpals JI; Bell JC; Dimitroulakos J
    Int J Cancer; 2012 Aug; 131(3):E204-15. PubMed ID: 22173567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production by human leukocytes with different expressions of natural antiviral immunity and the effect of antibodies against interferons and TNF-alpha.
    Orzechowska B; Antoszków Z; Siemieniec I; Lorenc M; Jatczak B; Błach-Olszewska Z
    Arch Immunol Ther Exp (Warsz); 2007; 55(2):111-7. PubMed ID: 17417691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretome Screening Reveals Fibroblast Growth Factors as Novel Inhibitors of Viral Replication.
    van Asten SD; Raaben M; Nota B; Spaapen RM
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of short hyperthermic treatment at specific stages of vesicular stomatitis virus replication cycle.
    De Marco A; Santoro MG
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1685-90. PubMed ID: 8393918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.
    Beq S; Delfraissy JF; Theze J
    Eur Cytokine Netw; 2004; 15(4):279-89. PubMed ID: 15627636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells.
    Korutla L; Kumar R
    Biochem Biophys Res Commun; 1996 Mar; 220(3):670-4. PubMed ID: 8607823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular stomatitis virus induces apoptosis in the Wong-Kilbourne derivative of the Chang conjunctival cell line.
    Gallyas E; Seprényi G; Sonkoly E; Mándi Y; Kemény L; Megyeri K
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):717-24. PubMed ID: 16328428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
    Dargan DJ; Galt CB; Subak-Sharpe JH
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
    Fagard C; Oxenius A; Günthard H; Garcia F; Le Braz M; Mestre G; Battegay M; Furrer H; Vernazza P; Bernasconi E; Telenti A; Weber R; Leduc D; Yerly S; Price D; Dawson SJ; Klimkait T; Perneger TV; McLean A; Clotet B; Gatell JM; Perrin L; Plana M; Phillips R; Hirschel B;
    Arch Intern Med; 2003 May; 163(10):1220-6. PubMed ID: 12767960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
    Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
    J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of a vesicular stomatitis virus infection in primary lymphocytes is restricted at multiple levels during B cell activation.
    Schmidt MR; Gravel KA; Woodland RT
    J Immunol; 1995 Sep; 155(5):2533-44. PubMed ID: 7650383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.